Daily Newsletter

28 September 2023

Daily Newsletter

28 September 2023

Acuitive obtains FDA clearance for new fixation device

The new device provides a compressive strength like cortical bone and a modulus similar to trabecular bone.

RanjithKumar Dharma September 28 2023

Acuitive Technologies has received 510(k) clearance from the US Food and Drug Administration (FDA) for its CITRELOCK DUO fixation device for biceps tenodesis.

The new sports medicine fixation device offers surgeons a differentiated design through a tendon-friendly spiral thread featuring the Citregen next-generation resorbable technology.

Citregen has advanced molecular and mechanical properties for orthopaedic surgical applications.

The new device consists of a biomimetic material composition for matching the native bone inorganic content as well as a soft spiral thread design for eliminating tendon laceration.

Featuring elastomeric properties for enhanced pull-out strength, it also provides compressive strength like cortical bone and a modulus similar to trabecular bone.

In addition, Citrelock duo delivers a controlled resorption rate to alleviate chronic inflammation.

Acuitive product development vice-president Rui Ferreira said: “Our customers are looking for a fixation device with unique mechanical properties that protects the tendon’s integrity during insertion while providing improved fixation within the bone tunnel.

“Additionally, the Citrelock duo provides more predictable resorption while avoiding the chronic inflammation reported with other biodegradable polymers.

“With its innovative Citregen material technology and unique thread design, the Citrelock duo fills the clinical need surgeons have been seeking.”

Acuitive is focused on the development of advanced biomaterials and orthopaedic devices that participate in the natural musculoskeletal tissues’ healing process and address the shortcomings of existing biomaterials.

Generative AI set to transform the medical devices industry

Generative AI can improve personalized healthcare by collecting data from patients via wearable devices, which can provide continuous, real-time data that can complement traditional data sources such as imaging, patient records, and more. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data through AI medical products could conflict with regulations around the globe.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close